Related Experiment Video
Updated: Jul 16, 2026

Methods Development for Blood Borne Macrophage Carriage of Nanoformulated Antiretroviral Drugs
Published on: December 9, 2010
Formulation of parenteral microemulsion containing itraconazole
Yun-Seok Rhee1, Chun-Woong Park, Tae-Young Nam
1College of Pharmacy, Sungkyunkwan University, Suwon 440-746, Korea.
This study developed a novel itraconazole (ITZ) parenteral formulation using an oil-in-water microemulsion. The optimized ITZ microemulsion demonstrated good stability and safety, showing potential for intravenous drug delivery.
Area of Science:
- Pharmaceutical Sciences
- Drug Delivery Systems
- Nanotechnology
Background:
- Itraconazole (ITZ) is an antifungal agent with poor aqueous solubility, limiting its parenteral administration.
- Developing stable and effective parenteral formulations is crucial for treating systemic fungal infections.
Purpose of the Study:
- To develop a stable aqueous parenteral formulation of itraconazole (ITZ) using an oil-in-water (o/w) microemulsion.
- To evaluate the suitability of the developed microemulsion for parenteral administration.
- To compare the pharmacokinetic profile of the ITZ microemulsion with existing formulations in rats.
Main Methods:
- Construction of pseudoternary phase diagrams to determine optimal microemulsion components (oil, surfactant, cosurfactant).
- Evaluation of microemulsion characteristics including droplet size analysis and hemolysis tests.
- Pharmacokinetic studies in rats comparing the ITZ microemulsion with PEG 400 solution and cyclodextrin formulations.
Main Results:
- An optimized o/w microemulsion formulation for ITZ was successfully developed.
- The microemulsion exhibited an average droplet size below 150 nm and demonstrated non-toxicity to red blood cells via hemolysis testing.
- The ITZ microemulsion showed promising pharmacokinetic profiles in rats compared to other tested formulations.
Conclusions:
- The developed itraconazole microemulsion is a suitable and safe candidate for parenteral drug delivery.
- This formulation offers a potential improvement over existing parenteral itraconazole options.
- Further investigation into this microemulsion system could advance antifungal parenteral therapy.
Related Concept Videos
Drug Delivery: Parenteral Route
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
Parenteral Drug Delivery Systems: Injectables, Implants, and Infusion Devices
Routes of Drug Administration: Parenteral
The intravenous route (IV) of drug administration can be further categorized into two types. The bolus injection administers the entire dose rapidly, while an intravenous infusion slowly delivers smaller doses steadily.
The IV route is often...
Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
Bioavailability Enhancement: Drug Permeability Enhancement
